Physician Preferences Define Fixationless Vaginal Sling Market
In a newly published report by Millennium Research Group (MRG), over 200 urologists and gynecologists from around the world identify the product characteristics, clinical factors, and vendor criteria that inform their fixationless sling usage patterns.
(PRWEB) August 3, 2005 -— Fixationless vaginal slings are recognized as the
gold standard treatment for urinary incontinence (UI), a condition that afflicts
millions of women worldwide. UI can have dramatic psychological repercussions,
affecting daily routines and personal relationships. Demand for minimally
invasive UI treatments and the expedient operating times and high efficacy rates
these devices offer, continues to drive the global adoption of fixationless
vaginal slings. Innovation has produced an onslaught of new products and
competitors over the past 4 years, fueling a global fixationless sling market
set to surpass $200 million by 2006. Manufacturers must possess a thorough
understanding of the preferences and attitudes of gynecologists and urologists
in order to effectively market fixationless slings in an increasingly
competitive global market.
In a newly published report by Millennium
Research Group (MRG), over 200 urologists and gynecologists from around the
world identify the product characteristics, clinical factors, and vendor
criteria that inform their fixationless sling usage patterns. The report reveals
that while urologists and gynecologists perform a similar volume of vaginal
sling procedures each month, gynecologists use fixationless products with
greater frequency. Despite an increased adoption of transobturator slings,
urologists and gynecologists also indicated that the availability of a vaginal
or transvaginal approach remains the most important characteristic governing the
selection of a fixationless sling. Respondents further identified ease-of-use
and associated infection rates as crucial determinates of product
satisfaction.
MRG’s Global Urologist and Gynecologist Survey 2005:
Fixationless Vaginal Sling Adoption & Usage Patterns examines respondent
preferences concerning fixationless vaginal slings offered by 14 suppliers,
including Johnson & Johnson (JNJ), American Medical Systems (AMMD), Mentor
Corporation (MNT), Bard Urological (BCR), and Boston Scientific (BSX).
A
leading source of competitive intelligence, MRG is now the largest provider of
medical device market research in the world. Located in Toronto, Canada, MRG
covers global markets and has pioneered reporting of numerous emerging
products.
Contact Information:
Harika Kalkat
Millennium Research
Group Inc.
+1 (416) 364-7776 ext. 111
e-mail protected from spam
bots
www.mrg.net
# # #
Source : http://www.prweb.com/releases/2005/8/prweb266515.htm